Salient Capital Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-2,299
| Closed | -$299K | – | 211 |
|
2017
Q2 | $299K | Sell |
2,299
-3,774
| -62% | -$491K | 0.01% | 178 |
|
2017
Q1 | $756K | Buy |
6,073
+832
| +16% | +$104K | 0.01% | 148 |
|
2016
Q4 | $607K | Buy |
5,241
+2,741
| +110% | +$317K | 0.01% | 161 |
|
2016
Q3 | $261K | Sell |
2,500
-559
| -18% | -$58.4K | 0.01% | 215 |
|
2016
Q2 | $302K | Buy |
3,059
+767
| +33% | +$75.7K | 0.01% | 212 |
|
2016
Q1 | $229K | Buy |
+2,292
| New | +$229K | 0.01% | 228 |
|